Oxazepam glucuronide solution, 100 mug/mL in methanol, ampule of 1 mL, certified reference material

Code: o-023-1ml D2-231

Not available outside of the UK & Ireland.

General description

Oxazepam glucuronide is a major urinary metabolite of the benzodiazepine drug, oxazepam. Oxazepam, marketed as Alepam, Medopam, or Murelax®

read more

Your Price
$238.47 1ML
Discontinued
$286.16 inc. VAT

Not available outside of the UK & Ireland.

General description

Oxazepam glucuronide is a major urinary metabolite of the benzodiazepine drug, oxazepam. Oxazepam, marketed as Alepam, Medopam, or Murelax®, has been used extensively since the 1960s for treatment of anxiety and insomnia and in the control of symptoms of alcohol withdrawal. This certified reference solution is suitable for GC/MS or LC/MS applications with oxazepam or oxazepam glucuronide such as urine drug testing, pain prescription monitoring, toxicology analysis, or forensic testing.

Legal Information

Snap-N-Spike is a registered trademark of Cerilliant Corporation

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

CERILLIANT is a registered trademark of Cerilliant Corporation

Murelax is a registered trademark of Aspen Pharma Pty Ltd

application(s)clinical testing
concentration100 µg/mL in methanol
drug controlNarcotic Licence Schedule B (Switzerland)
featureSnap-N-Spike®/Snap-N-Shoot®
formliquid
formatsingle component solution
gradecertified reference material
InChI keyFIKQKGFUBZQEBL-IFBJMGMISA-N
InChI1S/C21H19ClN2O8/c22-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)24-19(18(28)23-12)32-21-16(27)14(25)15(26)17(31-21)20(29)30/h1-8,14-17,19,21,25-27H,(H,23,28)(H,29,30)/t14-,15-,16+,17-,19?,21-/m0/s1
manufacturer/tradenameCerilliant®
packagingampule of 1 mL
Quality Level300
SMILES stringO[C@@H]1[C@@H](O)[C@H](OC2N=C(c3ccccc3)c4cc(Cl)ccc4NC2=O)O[C@@H]([C@H]1O)C(O)=O
storage temp.−20°C
technique(s)gas chromatography (GC): suitable, liquid chromatography (LC): suitable
Cas Number6801-81-6
Hazard Class3
Un Number1230
Pack Group2
This product has met the following criteria: